Nonagen Bioscience Corporation Is A Biotechnology Company Established In 2011Specializing In Advanced Diagnostics For Cancer Detection And Managementthe Company Is Dedicated To Translating Research Into Effective Diagnostic Tools That Assist Healthcare Providers In Disease Detectiontherapy Selectionand Monitoring Nonagen Primarily Offers Diagnostic Services Aimed At Improving The Detection And Management Of Bladder Cancertheir Lead Productoncuriais A Multiplex Immunoassay That Quantitatively Detects Biomarkers In Urine Associated With Bladder Canceroncuria Is Designed To Detect Bladder Cancer With High Sensitivity And Specificitymonitor Early Stage Patients For Recurrenceand Predict Responses To Bcg Therapyit Has Shown 93Sensitivity And Specificity In Clinical Studies And Received Breakthrough Device Designation From The Fda In September 2021 Headquartered In Houstontxnonagen Bioscience Is Led By A Team With Extensive Experience In The Diagnostics Industryincluding Coo Wayne Hogrefephdwho Oversees The Launch Of Oncuria And Its Fda Approval Process
No conferences found for this company.
| Company Name | Nonagen Bioscience Corporation |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
